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Abstract Next generation genomic sequencing technologies
(including whole genome or whole exome sequencing) are
being increasingly applied to clinical care. Yet, the breadth
and complexity of sequencing information raise questions
about how best to communicate and return sequencing infor-
mation to patients and families in ways that facilitate compre-
hension and optimal health decisions. Obtaining answers to
such questions will require multidisciplinary research. In this
paper, we focus on how psychological science research can
address questions related to clinical genomic sequencing by
explaining emotional, cognitive, and behavioral processes in
response to different types of genomic sequencing informa-
tion (e.g., diagnostic results and incidental findings). We
highlight examples of psychological science that can be ap-
plied to genetic counseling research to inform the following
questions: (1) What factors influence patients’ and providers’
informational needs for developing an accurate understanding
of what genomic sequencing results do and do not mean?; (2)
How and by whom should genomic sequencing results be
communicated to patients and their family members?; and
(3) How do patients and their families respond to uncertainties
related to genomic information?
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Next generation genomic sequencing technologies (including
whole genome or exome sequencing) have considerable po-
tential as clinical tools because they simultaneously analyze
millions of gene variants (Bick and Dimmock 2011; Facio,
Lee, and O’Daniel 2014). Yet, a substantial portion of the
genetic variation that genomic sequencing uncovers is of
uncertain significance due to current limitations in knowledge
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about genetic causes of disease (Berg, Khoury, and Evans
2011). Genomic sequencing can also yield incidental or “sec-
ondary” findings—genetic information that is unrelated to the
main reason for which sequencing was conducted (Lohn,
Adam, Birch, and Friedman 2014). Incidental findings vary
greatly in their clinical validity and utility, and recommenda-
tions for returning this information will likely change with
advances in genomic science (Green et al. 2013). The in-
creased interest in genomic sequencing has also raised discus-
sions regarding informed consent, protection of privacy, and
security of health records (Burke et al. 2013; Green et al.
2013; McGuire et al. 2008; Presidential Commission 2012).
Much of the concern surrounding return of sequencing
information focuses on (a) what, when, how, and by whom
this information should be communicated and (b) how it may
be understood and used by patients and their family members
(Berg et al. 2011; Biesecker, Burke, Kohane, Plon, and
Zimmern 2012; Cho 2008). Genetic counselors will be on
the frontlines of translating genomic sequencing to clinical
care and grappling with these issues in their practice and
conducting research to develop best practice guidelines
(Bernhardt 2014; Hooker, Ormond, Sweet, & Biesecker,
2014; Mills and Haga 2013; Ormond 2013). The aim of this
paper is to provide some examples of how psychological
science can inform multidisciplinary research on the above
issues, and ultimately, provide an empirical basis for genetic
counseling practice.
Psychological science encompasses many areas of special-
ization that can offer explanations for emotional, cognitive,
and behavioral responses to sequencing information (See
Table 1; King 2008; Patenaude, Guttmacher, and Collins
2002; Tercyak, O’Neill, Roter, and McBride 2012). For ex-
ample, cognitive psychologists have investigated how people
process information and make decisions; social psychologists
have investigated how people influence each other’s feelings,
thoughts, and behaviors; health psychologists have investigat-
ed how people cope with stress; and clinical psychologists
have investigated causes of and treatments for emotional
distress. Psychological and behavioral processes have been
investigated using people’s self-reports in surveys and
qualitative interviews as well as observations of their physio-
logical responses (e.g., heart rate) and behavioral responses
(e.g., information seeking) in laboratory and field settings.
The variety of methods used in psychological science neces-
sitates quantitative statistics and qualitative analyses to inves-
tigate psychological and behavioral processes. This diversity
of research areas, methodologies, and analyses in psycholog-
ical science enables genetic counseling research to address a
wide range of practice questions related to clinical genomics.
We organize our discussion of applying psychological
science to genetic counseling research around three critical
questions that were identified by clinicians and researchers in
the Phase 1 Clinical Sequencing Exploratory Research
Program consortium (Baylor College of Medicine, Brigham
and Women’s Hospital , Children’s Hospital of
Philadelphia, Dana-Farber Cancer Institute, University of
North Carolina, Chapel Hill, University of Washington; for
more information about the consortium, see http://www.
genome.gov/27546194):
1) What factors influence patients’ and providers’ informa-
tional needs for developing an accurate understanding of
what genomic sequencing results do and do not mean?
2) How and by whom should genomic sequencing results be
communicated to patients and their family members?
3) How do patients and their families respond to uncer-
tainties related to genomic information?
Q1: What Factors Influence Patients’ and Providers’
Informational Needs for Developing an Accurate
Understanding of What Genomic Sequencing Results
Do and Do Not Mean?
Qualitative research suggests that people often anticipate
some level of personal utility from learning sequencing infor-
mation (Facio, Brooks, Loewenstein, Green, Biesecker, and
Biesecker 2011; Miller et al. 2014; Sapp et al. 2014). Yet,
people’s understanding of the relationship of genetics to health
Table 1 Examples of different areas of psychological science (King 2008)
Area Description Examples of research
Cognitive Investigating attention, consciousness, information processing, and
memory
Learning, decision making
Social Investigating social interactions, relationships, perceptions of oneself
relative to others, and attitudes
Social support, discrimination
Health Investigating psychological factors affecting health, lifestyle behaviors,
and health care
Stress and coping, illness management
Personality Investigating enduring individual characteristics Personality traits, motivation
Developmental Investigating factors contributing to human development Language development, aging and memory
Clinical Investigation and treatment of clinical disorders Mental disorder treatments, classification of mental disorders
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appears to be based more on personal experiences and pre-
vailing cultural views than scientific or clinical knowledge
(Condit 2010). At the same time, the shortage of genetics
specialists relative to the growing demand for clinical geno-
mics (Bernhardt 2014) means that the remaining gaps are
likely to be filled by providers with variable levels of training
in genetics and genomic medicine (Feero and Green 2011).
National surveys reveal that although most physicians recog-
nize the potential benefits of genetic information for clinical
care, many are ill-equipped to order genomic sequencing due
to limitations in their genetics education and training and lack
of awareness of available testing resources (Haga, Burke,
Ginsburg, Mills, and Agans 2012; Stanek et al. 2012).
People have different informational needs for understand-
ing their genomic sequencing information (Schmidlen,
Wawak, Kasper, García-España, Christman, and Gordon
2014). Knowing how and what to communicate about gene
variants, disease risk, and health implications has proven
challenging (Biesecker et al. 2012; Lautenbach, Christensen,
Sparks, and Green 2013) and will be further complicated by
the return of incidental findings (Bernhardt 2014; Facio et al.
2014; Hooker et al. 2014). Research is needed to clarify
factors that shape the informational needs of patients and
providers for understanding genomic sequencing information.
Elucidating such factors could, for instance, inform guidelines
for communicating different types of sequencing information
to patients; inform health care provider education and training;
and help genetic counselors anticipate patients’ needs for
support systems or clinical services. Some examples of factors
whose investigation could be informed by psychological sci-
ence include patients’ and providers’ expectations for se-
quencing information; emotions surrounding sequencing in-
formation and subsequent decision-making; and ability to
derive meaning from sequencing information.
Patient and Provider Expectations How might patients’ ex-
pectations influence their responses to sequencing results?
How might providers’ expectations influence their interpreta-
tion and communication of sequencing information?
Expectations are characterized as beliefs about the probability
of future outcomes (e.g., personal and social costs and benefits
to engaging in a certain behavior; Bandura 2004) that develop
largely as a result of personal and vicarious experiences
(Olsen, Roese, and Zanna 1996). Notably, what people expect
to happen may be distinct from what they hope will happen
(Leung, Silvius, Pimlott, Dalziel, and Drummond 2009).
People’s hopes for future outcomes are posited to reflect their
preferred outcomes, which may or may not correspond with
their expected outcomes. For example, a patient may expect
and hope to get a positive result from genomic sequencing; or
expect an uninformative result but hope for a positive result.
The implications of the discrepancies between hopes and
expectations are not yet clear.
Psychological research has shown that expectations can
influence how people process information. When people have
strong expectations for an outcome, they are likely to exhibit a
confirmation bias—they tend to seek and attend to informa-
tion that is consistent, rather than inconsistent, with their
expectations (Bandura 2004; Hart, Albarracín, Eagly,
Brechan, Lindberg, and Merrill 2009; Higgins and Bargh
1987; Johnston 1996). However, research suggests that con-
firmation biases can be attenuated. For example, when people
evaluate information, diverting their focus from their expec-
tations to the information itself can make their attitudes less
polarized (Hernandez and Preston 2013) and decrease biased
information-seeking (Jonas, Traut-Mattausch, Frey, and
Greenberg 2008). Patient and provider expectations for se-
quencing outcomes could affect their psychological and be-
havioral responses to sequencing information. For example,
patients who strongly expect to find a definitive genetic ex-
planation for their condition may question the veracity of a
negative or uninformative sequencing result. One potential
implication of this response is that patients may hesitate to
follow medical recommendations that are based on unexpect-
ed sequencing results. Providers who strongly suspect a ge-
netic cause for a disorder in their patient could, for example,
give more clinical significance to uncertain diagnostic find-
ings than warranted.
Emotions Surrounding Sequencing How do patients’ emo-
tions surrounding different types of sequencing information
influence their understanding and subsequent health deci-
sions? How might providers’ emotions surrounding sequenc-
ing information influence their willingness to order sequenc-
ing? Emotions are largely characterized as feelings of pleasure
(e.g., happiness, relief) or displeasure (e.g., sadness, anger) in
response to an event or experience (Barrett Feldman,
Mesquita, Ochsner, and Gross 2007). Discussions surround-
ing the potential for patient distress in response to sequencing
information typically focus on patient emotions as outcomes
(Biesecker et al. 2012; Cho 2008). Psychological research
highlights the importance of also investigating emotions as
potential predictors of responses to sequencing. For example,
anxiety is shown to increase people’s attentiveness to threat-
ening information (Vuilleumier 2005). Negative emotions
(e.g., anxiety, depression) are also shown to motivate people
to take action to blunt their distress or to avoid the source of
distress (Frijda 1986). Patients’ emotional responses to their
sequencing information could affect how they process and
seek genetic information. For example, patients who are dis-
tressed by their diagnostic sequencing results may avoid seek-
ing further information and/or avoid discussions involving
genetic information. In fact, evidence suggests that patients’
negative emotions can undermine communication of genetic
information to family members and uptake of genetic testing
by at-risk family members (Landsbergen, Verhaak, Floor, and
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Hoogerbrugge 2005). Compared to less distressed patients,
patients who are highly distressed may also be less willing to
learn incidental information (e.g., if they fear it could raise
additional health concerns).
Positive or negative feelings about an activity or event can
also serve as “information” that influences people’s risk per-
ceptions and health decisions (Peters, Lipkus, and Diefenbach
2006; Slovic, Peters, Finucane, and MacGregor 2005).
Specifically, evidence suggests that people’s judgments of an
activity (e.g., cancer screening) are based, in part, on their
positive or negative feelings about it. When people have
positive feelings about activities, they view them as having
high benefit and low risk; negative feelings about an activity
have the opposite effects. People’s feelings about an activity
are theorized to precede and shape their beliefs about risk and
benefit (Slovic et al. 2005).
Patients’ feelings about receiving different types of se-
quencing information (e.g., negative diagnostic results; posi-
tive, but non-medically actionable incidental findings) may
affect their decisions about whether or not to learn certain
types of sequencing information. For example, patients who
have positive feelings about genetic information may want to
learn ‘all the information’ they can from their genomic se-
quencing. Patients who feel less positively may be more
selective about what information they want to learn.
Likewise, providers’ feelings about, for example, the possi-
bility of needing to return incidental findings from diagnostic
genomic sequencing (e.g., sequencing results for adult-onset
diseases in minors) may influence their willingness to order
genomic sequencing for diagnostic purposes. Providers who
have negative feelings about returning incidental information
may be less willing to order genomic sequencing than pro-
viders who feel less negatively.
Further, when anticipating future emotional responses to an
outcome (affective forecasting), people often overestimate the
intensity and duration of their emotional responses to a future
event (Wilson and Gilbert 2003). Affective forecasting has
been used to highlight biases that can systematically shape
patients’ medical decisions and provider recommendations.
First, patients may place greater weight on how they think
their lives will be different than on what may actually stay the
same after a medical diagnosis or decision. Second, patients
may not recognize how their current emotional or physical
states influence their expectations (Halpern and Arnold 2008;
Winter, Moss, and Hoffman 2009). Third, patients and pro-
viders may underestimate how quickly patients make sense of
events and adjust their personal values to new situations
(Halpern and Arnold 2008; Rhodes and Strain 2008; Wilson
and Gilbert 2003). Affective forecasting could have implica-
tions for patient willingness to learn—and provider willing-
ness to order or return—different types of sequencing infor-
mation. For example, patients who expect to be distressed by
their genetic information may be more anxious about learning
incidental findings out of fear of prolonged worrying after-
wards. Conversely, patients who expect to feel more
empowered may seek to learn incidental findings, believing
that being “forewarned is forearmed.” Likewise, providers
who fear prolonged distress or maladaptive health care deci-
sions in patients may be hesitant to order genomic sequencing
or return incidental findings.
MakingMeaning from Complex Information How do patients
and providers infer health implications from complex se-
quencing information that is presented in the form of proba-
bilities, patterns of inheritance, and degrees of penetrance?
Psychological research suggests that patients and providers
are unlikely to incorporate all of the different pieces of infor-
mation regarding the sequencing output (or its caveats) into
their interpretation of findings. For example, people often
simplify complex information by drawing on personal expe-
riences and anecdotal knowledge of other people’s experi-
ences or by comparing their situation to what they think of
as a “typical situation” (McDowell, Occhipinti, and Chambers
2013; Tversky and Kahneman 1974). People also generally
simplify complex information into a bottom-line meaning, or
“gist” (Reyna 2008). Gists are also informed by context and
personal experiences (e.g., “Mom and her sisters died from
cancer, and my brother had it; cancer runs in the family; my
cancer must be genetic”). However, when simplification of
complex health information is based on inaccurate represen-
tations of situations, patients run the risk of maladaptive
medical decision making (Senay and Kaphingst 2009) and
providers run the risk of making ineffective or harmful rec-
ommendations (Enkin and Jadad 1998). Such simplifications
are especially problematic because patients may base medical
decisions more on their perceptions of their condition than
their actual results from medical testing (Reyna 2008; Vos
et al. 2012).
Examples of Research Directions for Q1 Research on such
topics as expectations, emotions (and anticipated emotional
responses), and derivation of meaning could inform an em-
pirical basis for determining how to address patients’ and
providers’ informational needs. For example, research on
expectations could include investigating factors that may
shape patient and provider expectations to identify subgroups
of patients and providers likely to need tailored genetics
education and assistance with comprehension of sequencing
information. Research on patients’ emotions surrounding se-
quencing could include investigating patients’ emotional re-
sponses—or anticipated responses—to different types of se-
quencing information and their effects on patient comprehen-
sion and subsequent health decision making. Research could
also investigate provider assumptions about patients’ feelings
and beliefs about different types of sequencing and their
effects on provider recommendations for genomic sequencing
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and provider communication of sequencing information.
Finally, research on patients’ and providers’ inferences about
health implications from sequencing information could in-
clude investigating how they develop a gist understanding of
sequencing information to identify areas of misunderstanding.
Q2: How Should Genomic Sequencing Results
be Communicated to Patients and Their Families,
and from Whom Should this Communication Come?
The breadth and complexity of sequencing information create
considerable difficulties for patient-provider communication
and informed decision making by patients. These difficulties
are further compounded by the interplay among the public’s
perceptions and fears about genetic information, poor health
literacy, and the inability of health care systems and providers
to keep up with advances in genomic science and medical
technologies (Feero and Green 2011; Johnson, Case,
Andrews, and Allard 2005; Lea, Kaphingst, Bowen, Lipkus,
and Hadley 2011). Research is needed to develop guidelines
for streamlining communication of different kinds of sequenc-
ing information (e.g., diagnostic, incidental; medically action-
able, non-medically actionable) and develop empirically-
based patient education strategies that maximize comprehen-
sion and informed decision making (Haga, Mills, and
Bosworth 2014). Some examples of where psychological
science could inform the second overarching question include
research on communication formats for sequencing informa-
tion (e.g., text, numbers, graphs); communication strategies
(e.g., message framing, narratives, tailoring); and impact of
the provider of sequencing information.
Communication Format How can genetic counselors present
genomic sequencing information in ways that are accessible to
patients? A major challenge to communication and compre-
hension of sequencing information is that different people will
have different needs for comprehending sequencing-related
details (Schmidlen et al. 2014). For example, low patient
literacy (i.e., inadequate knowledge and skills to search,
comprehend, and use information from text or numbers;
Kutner, Greenberg, Jin, Paulsen, and White 2006) has led to
calls to investigate ways to communicate genetic information
that take into account patient literacy levels (Lea et al. 2011;
McBride, Koehly, Sanderson, and Kaphingst 2010). Reviews
suggest that communication formats that can decrease literacy
demands include presenting numerical information in tables,
pictographs, and natural frequencies; avoiding overly com-
plex terminology when possible; limiting the range of infor-
mation presented; starring or otherwise highlighting key
points in text; and using videos to highlight important infor-
mation (McCaffery et al. 2013; Trevena et al. 2013). Likewise,
genetic counselors may benefit from using health literacy or
genetic /genomic testing knowledge assessments to determine
patients’ informational needs and tailor their communication
of sequencing information accordingly.
Communication Strategies: Message Framing How can ge-
netic counselors frame sequencing information in a way that
promotes clinically appropriate decision making by patients?
Health messages that encourage an action can be framed in
terms of gains (benefits) from engaging in the action or losses
(costs) from not engaging in the action (Gallagher and
Updegraff 2012; Rothman and Salovey 1997). For example,
smoking cessation can be framed in terms of a gain, “If you
stop smoking, you’ll reduce your chance of getting another
heart attack” or in terms of a loss, “If you do not stop smoking,
you’ll increase your chance of getting another heart attack.”A
recent review of health framing studies found that for actions
intended to prevent illness (e.g., smoking cessation), people
were on average more likely to take action in response to a
gain framed message than to a loss framed message
(Gallagher and Updegraff 2012). By contrast, for actions
intended to detect illness or risk (e.g., mammograms), people
were marginally more likely to take action in response to loss
framed messages than gain framed messages (Gallagher and
Updegraff 2012).
Framing effects could influence patients’ responses tomed-
ically actionable sequencing information by, for example,
influencing uptake of surveillance activities (e.g., when high
genetic risk warrants action), treatment (e.g., when finding an
explanatory gene variant leads to a diagnosis), or information
sharing (e.g., discussing findings with other health care pro-
viders or family members). However, it is unclear how fram-
ing effects would influence patient responses to sequencing
information that is not medically actionable (i.e., gene variants
for conditions that are not preventable or do not have a well-
defined treatment). Further, evidence suggests that framing
effects on health decisions vary by patient literacy, health
beliefs, and perceived difficulty of adhering to a recommen-
dation (Rothman and Salovey 1997).
Communication Strategies: Narratives How effective are nar-
ratives—relative to traditional genetic counseling interac-
tions—for helping streamline communication of sequencing
information? Narratives can be constructed to relate the same
messages as more traditional didactic forms of health commu-
nication, but in a story format that describes scenes, charac-
ters, and conflict; raises unanswered questions or unresolved
conflicts; and provides resolution to those questions and con-
flicts (Hinyard and Kreuter 2007; Kreuter et al. 2007). Stories
within narratives may be fictional or non-fictional, and they
may be based on firsthand experience, secondhand stories of
others, a position of a group, or culturally common themes
(Hinyard and Kreuter 2007). Evidence suggests that narratives
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can facilitate health information processing and understand-
ing, promote learning (e.g., by modeling desired behaviors),
overcome resistance to enacting health behaviors, and help
people understand the psychological and social implications
of health decisions (Green and Brock 2000; Kreuter et al.
2007; Murphy, Frank, Chatterjee, and Baezconde-Garbanati
2013). The use of narratives to promote understanding of
genomic sequencing information and informed decision mak-
ing (e.g., as online or written decision aid materials) could be a
promising supplement to traditional genetic counseling inter-
actions. However, it is currently unclear how narratives com-
pare to traditional clinician-patient interactions in helping
patients understand and make decisions based on complex
and often nuanced sequencing information.
Communication Strategies: Tailoring How can genetic coun-
selors tailor genomic sequencing information to the patient
and how does such tailoring affect patient understanding and
health decisions? A review suggests that people are more
likely to attend and respond to health information if its rele-
vance is tailored to them (Noar, Benac, and Harris 2007). The
efficacy of tailoring can be explained by various psychologi-
cal mechanisms, including increased attention (and, by exten-
sion, comprehension) and greater perceived relevance to per-
sonal goals, circumstances, and experiences (Hawkins,
Kreuter, Resnicow, Fishbein, and Dijkstra 2008). In turn,
information perceived as more personally relevant is more
likely to be carefully processed (e.g., greater attention to
information content; greater integration of information with
the person’s own knowledge and experience; Petty and
Wegener 1999).
There are numerous ways genomic sequencing information
could be tailored. For example, information could be tailored
to individual differences such as patients’ need for cognition,
which reflects the degree to which people prefer to think
deeply and prefer to get more detailed, elaborate explanations
over briefer and simpler explanations (Cacioppo and Petty
1982). Recommendations for applying genomic information
to health decisions could also be tailored to the individual’s
values, goals and life stage. Additionally, tailoring information
to patients’ level of health literacy could promote understand-
ing of complex sequencing information. However, tailored
approaches can be difficult to implement in some settings
because up-front assessments are needed to guide tailoring,
and providers have to be flexible in their style of communi-
cation (Noar et al. 2007). Nonetheless, research has docu-
mented effective ways to develop tailored print materials
(Noar et al. 2007), and interactive web-based software pro-
grams can facilitate baseline assessment and customized feed-
back (Krebs, Prochaska, and Rossi 2010).
The Impact of the Provider of Sequencing Information How
might patients’ comprehension and subsequent use of
genomic sequencing information vary in response to receiving
them from different health care providers (e.g., genetic coun-
selors, specialist, family physician)? As applications of geno-
mic sequencing become widespread, there will be correspond-
ing increases in the diversity of settings in which sequencing
results are communicated (Bick and Dimmock 2011; Berg
et al. 2011). Patients are more likely to trust health information
from providers who are known to them and who they perceive
as understanding their background and motivations (Kreuter
and McClure 2004; Lewis et al. 2000). Yet, the lack of
uniformity in genomics education and training across health
care professions (Feero and Green 2011) may cause some
providers to refer patients and families to specialists with more
expertise in genome medicine.
It is currently unclear how patients would comprehend and
make informed health decisions from sequencing information
they received from different providers. Psychological science
research on persuasive messaging suggests that people’s re-
ceptivity to messages from different sources is influenced by a
combination of source, message, and recipient factors. For
example, for people who are highly motivated to attend to a
message, evidence suggests that source credibility or expertise
matters more when the message is ambiguous or neutral than
when a message clearly favors a certain position (Chaiken and
Maheswaran 1994). Evidence also suggests that when people
disagree with a message, they scrutinize strongly argued mes-
sages from experts more than strongly argued messages from
non-experts (Clark, Wegener, Habashi, and Evans 2012).
However, when they agree with the message, people may
scrutinize weakly argued messages more from non-experts
than experts. These findings suggest that the difference a
provider’s expertise makes on patient responses to sequencing
information could depend on factors such as the clarity of
information provided or the degree to which the information
meets patients’ expectations or hopes.
Examples of Research Directions for Q2 Investigating such
areas as communication formats, communication strategies
(e.g., framing, narratives, tailoring), and impact of the provid-
er of sequencing information could inform development of
guidelines for communicating different types of sequencing
information in ways that promote comprehension and in-
formed decision making. For example, research on commu-
nication formats could include comparing the effects of visual
aids, decision aids, and different communication mediums
(video, online) on patient comprehension and decisionmaking
across different levels of literacy. Research on framing could
include comparing the effects of gain framed to loss framed
communication of diagnostic and incidental sequencing infor-
mation on patient understanding and health decisions.
Research on narratives could include investigating the relative
efficacy of supplementing traditional didactic clinician-
provider communication with narratives. Research on
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tailoring could include comparing the effects of different
tailoring methods (e.g., by health literacy, need for cognition)
on patient health decisions and the feasibility of applying
tailoring across different clinical contexts. Finally, research
on providers of sequencing information could include inves-
tigating how patient comprehension of genomic sequencing
information—and subsequent health decisions—vary as a
function of the health care provider returning results.
Q3: How do Patients and their Families Respond
to Uncertainties Related to Genomic Information?
In health contexts, uncertainty is a multidimensional construct
that is characterized as feeling a sense of ignorance because of
the probable nature of health risks and the ambiguity and
complexity of health information (Han, Klein, and Arora
2011). Uncertainty in health contexts can arise from limita-
tions in scientific knowledge (e.g., limited evidence about a
treatment’s efficacy), limitations within health care systems
(e.g., treatment accessibility), and patients’ illness uncertainty
(Han et al. 2011). Patients’ illness uncertainty is characterized
by an inability to make sense of illness-related events because
patients are unable to identify the cause of their illness, define
their illness, or make predictions about their future health
(Han et al. 2011; Mishel 1990). Although illness uncertainty
is thought to be anxiety-provoking (Sweeny and Cavanaugh
2012), some patients may capitalize on it to allay distress from
the certainty of negative health outcomes (Mishel 1990; Case,
Andrews, Johnson, and Allard 2005). However, when patients
view illness uncertainty as threatening or as a barrier to their
goals, it can elicit distress (e.g., anxiety, depression) (Baum,
Friedman, and Zakowski 1997; Case et al. 2005;Mishel 1990)
and impede decision making and communication of health
concerns with others (Baum et al. 1997; Hamilton et al. 2013;
Johnson Wright, Afari, and Zautra 2009; Neville 2003). Such
effects of illness uncertainty may depend on the source of
uncertainty. For example, decisional implications of uncer-
tainty about the probability of a treatment’s efficacy appear
to be distinct from decisional implications of uncertainty from
a lack of information or conflicting expert opinions and sci-
entific evidence (Hamilton et al. 2013).
Genomic sequencing can potentially reduce patients’ ill-
ness uncertainty by identifying the cause of a previously
unexplained or undiagnosed condition. However, genomic
sequencing will also perpetuate illness uncertainty by yielding
genetic information (diagnostic, incidental) with unclear clin-
ical validity and utility; probabilistic health implications; and
clinical implications that are likely to change over time with
advances in genomic science (e.g., uncertain diagnostic results
may be later re-classified as positive or negative results) (Berg
et al. 2011; Green et al. 2013). Some examples of how
psychological science could inform research on the third
overarching question include clarifying how patients cope
with uncertainty from sequencing information individually
(e.g., their personal responses) and with others (e.g., process-
ing information by talking with others) and their effects on
patient psychological and behavioral responses to sequencing
information. Such research could, for instance, inform the
development of educational and support resources for patients
and families (McClellan et al. 2013); guidelines for commu-
nicating sequencing information; and testable models for an-
ticipating patient decisions about learning different types of
sequencing information as well as their responses to receiving
that information.
Individual Ways of Managing Uncertainty How might pa-
tients respond to uncertainty in their sequencing information?
In one study, responses to uncertainty from sequencing infor-
mation by research participants were found to stem from their
personal beliefs about the extent to which uncertainty in
sequencing information is expected or normal (Biesecker
et al. 2014). Participants with more optimistic attitudes or
greater tolerance for ambiguity in sequencing information
were more likely to view uncertainty as a source of opportu-
nity. In contrast, participants who viewed uncertainty nega-
tively or as something unexpected from sequencing informa-
tion were more likely to perceive uncertainty in sequencing
information as distressing or question its veracity. These find-
ings suggest that patients who are more tolerant for uncertain-
ty in sequencing information may be more likely to remain
hopeful about the clinical possibilities of genomic sequencing
technologies than patients who are less tolerant of uncertainty.
When uncertainty is deemed stressful, patients may engage
in various efforts to manage their stress. One line of research
on stress management suggests that people manage stress by
either seeking or avoiding information related to the stressor.
Some people tend to be monitors who actively seek informa-
tion (e.g., scouring the Internet for relevant content), believing
that “knowledge is power” (Miller 1987). Other people tend to
be blunters who avoid such information, perceiving that “ig-
norance is bliss”. Evidence also shows that that monitors are
more likely than blunters to ask questions and express emo-
tions during clinic encounters, have longer clinic encounters,
and experience more post-decisional regret about treatment
decisions (Timmermans, van Zuuren, van der Maazen, Leer,
and Kraaimaat 2007). Another line of research suggests that
patients maymanage anxiety they experience before receiving
uncertain health information (e.g., results from a tumor biop-
sy) by adjusting their expectations for positive outcomes,
planning ways to manage distress in case of bad news, or
finding ways to distract themselves from thinking about the
impending health news (Sweeny and Cavanaugh 2012). Thus,
such factors as individual differences in coping preferences
and patient attempts to brace for potentially unpleasant health
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information could have important implications for how they
respond to sequencing information. For example, relative to
blunters, monitors may be more tolerant of uncertainty in their
sequencing information and experience less distress in re-
sponse to diagnostic results and incidental findings. Yet,
blunters may be more likely to brace for potentially undesir-
able sequencing information and take precautionary measures
to cushion themselves from distress.
Interpersonal Ways of Managing Uncertainty How might
family and community social dynamics influence patient re-
sponses to uncertainty surrounding sequencing information?
Responding to illness uncertainty can extend beyond the
individual patient to include family members. This is espe-
cially true of genetic information, where one family member’s
testing or sequencing results can impact how other family
members view their own risk for illness (Dancyger, Smith,
Jacobs, Wallace, and Michie 2010; McBride et al. 2010).
Families often manage distress by encouraging disclosure of
distress and engaging in collective efforts to comfort each
other and generate potential solutions (Berg and Upchurch
2007; Mickelson, Lyons, Sullivan, and Coyne 2001). This
shared coping often occurs when family members share a
sense of responsibility for helping each other through difficult
situations (Mickelson et al. 2001). These kinds of collabora-
tive family social dynamics could, for example, facilitate
exchange of disease-risk information within families and en-
courage uptake of genetic counseling or testing services by at-
risk family members (Dancyger et al. 2010; Peterson 2005).
However, family members can also undermine each other’s
attempts to manage uncertainty by avoiding or otherwise
discouraging disclosure of distress. For instance, family mem-
bers may be uncomfortable with their loved one’s distress or
they may want to avoid family conflict regarding genetic
information (Peterson 2005; Lepore and Revenson 2007).
Under such circumstances, families may develop patterns of
interaction that discourage discussion of personal fears and
concerns. Further, some patients may prefer to keep their fears
and concerns to themselves. For example, they may want to
protect family members from distress, avoid discussion of
difficult topics, or avoid negative experiences they had in the
past when sharing their distress with others (Lepore and
Revenson 2007; Peters et al. 2011; Peterson 2005). Such
“social constraints” could, for example, reduce the likelihood
that patients share important information related to family
disease risk and hinder their ability to understand and make
sense of their sequencing information.
In addition, the ways in which patients and families re-
spond to uncertainties related to genomic sequencing infor-
mation could be shaped by their larger social network and
surrounding community. When people have limited direct
experience on which to base their expectations for future
events or outcomes, they may refer to the experiences of
others (Bandura 1997; 2004). By extension, patients and
unaffected or at-risk family members may look to the experi-
ences of their friends, co-workers, neighbors or fellow mem-
bers of religious or civic organizations to inform their beliefs
about genetics and its health implications. Further, people turn
to social media (e.g., Facebook, Twitter) to increase health
knowledge, supplement provider communication, exchange
social support and advice, learn or share a health status, and
share illness-related experiences (Antheunis, Tates, and
Nieboer 2013; Thackeray, Crookston, and West 2013).
However, patients and their family members may need edu-
cation about the potential risks of sharing sequencing infor-
mation through social media (Prince and Roche 2014). For
example, they may not realize that sharing sequencing infor-
mation through Facebook could inadvertently undermine their
or their family members’ legal privacy protections from em-
ployers and insurers.
Examples of Research Directions for Q3 Investigating pa-
tients’ individual and interpersonal coping processes sur-
rounding sequencing information could provide a more nu-
anced understanding of patient and family responses to uncer-
tainty in sequencing information. For example, research on
individual coping processes could include investigating the
effects of individual differences in patients’ coping prefer-
ences (e.g., tendencies to be a monitor or blunter in response
to distressing information or general coping styles) on pa-
tients’ psychological responses to sequencing information,
communication of sequencing information with others (e.g.,
family members, health care providers), and application of
sequencing information to health decisions. Research on so-
cial dynamics surrounding genomic sequencing information
could include investigating the effects of patient preferences
for disclosure or shared decision making with close family
members, friends, and other extended social network mem-
bers on patient-level and family member-level psychological
and behavioral outcomes. Finally, another research direction
could be to investigate the effects of family and extended
network social dynamics on patient psychological and behav-
ioral responses to sequencing information as a function of the
type of sequencing information returned (e.g., diagnostic re-
sults, incidental findings).
Conclusions
Next generation sequencing technologies offer considerable
potential for the explanation of unexplained or difficult-to-
diagnose diseases. However, current technological capabili-
ties and demands for clinical translation seem to outpace
current knowledge about the clinical validity and utility of
many of the gene variants obtained from genomic sequencing.
200 Khan et al.
Multidisciplinary research aimed at developing guidelines for
applying sequencing technologies is currently underway, and
the need for such research will only increase with continuing
advances in genomic science and medicine. The experiences
and research of genetic counselors are crucial to meeting this
need.
Questions about communicating sequencing information
and helping patients and families understand it can be ad-
dressed, in part, by applying research from psychological
science to genetic counseling research. For example, psycho-
logical studies in cognition, communication, and decision
making suggest that expectations, emotions, and biases in
thinking about complex and uncertain information can shape
patient-provider understanding and communication.
Psychological studies on cognition, social processes, health,
and communication suggest that patients’ literacy, preferences
for information, perspectives on their health, and views of
different providers are important factors to consider when
communicating sequencing information. Psychological stud-
ies on social processes and health also suggest that patient and
family responses to uncertainties in genomic information may
be shaped by individual or family differences in communica-
tion and coping preferences.
The cited examples of psychological science, as well as the
examples of research directions, reflect a small subset of
psychological theory and research. The breadth of psycholog-
ical research on emotional, cognitive, and behavioral process-
es span well over a century, making an exhaustive review of
all of the potential applications of psychological science to
clinical translation of genomic sequencing impossible. At the
same time, this breadth provides a rich basis for advancing
scientific understanding of patient-provider communication
and patients’ and families’ psychological and behavioral re-
sponses surrounding the complexities of genomic sequencing.
Additional examples of psychological science that were not
discussed but could also inform genetic counseling research
include (but are not limited to) the literature on illness repre-
sentations (Marteau and Weinman 2006), stigma (Major and
O’Brien 2005), locus of control (Cheng, Cheung, Chio, and
Chan 2013), and cognitive dissonance (Harmon-Jones,
Amodio, and Harmon-Jones 2009).
Findings from the psychological science research cited in
this paper come from a variety of study contexts (e.g., field
research, laboratory settings) and participant populations (e.g.,
cancer patients, healthy young adults). The degree to which
such findings will replicate in the context of clinical genomics
is an empirical question. Yet, it is possible that the psycholog-
ical, social, and behavioral implications of sequencing infor-
mation are much like those of other health (e.g., cancer risk) or
social (e.g., predicting someone else’s behaviors) contexts in
the sense of being complex, ambiguous, and having unclear
long-term implications. The richness and breadth of psycho-
logical science offers a significant resource for genetic
counseling research to investigate ways to maximize the ben-
efits and minimize the harms of clinical genomic sequencing.
Further, the range of different types of research methodologies
(e.g., quantitative survey research, qualitative observational
studies) employed in psychological science demonstrate the
value of implementing multiple research methods to address a
wide range of research questions. We hope that the examples
of psychological science in this paper will generate innovative
research that addresses critical questions about clinical appli-
cations of genomic sequencing technologies and inform ge-
netic counseling practice.
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